Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of depression in amyotrophic lateral sclerosis/motor neuron disease: multi-attribute ascertainment and trajectories over 30 months.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2022
Same author

Inhibition of HERV-K (HML-2) in amyotrophic lateral sclerosis patients on antiretroviral therapy.

Journal of the neurological sciences·2021
Same author

Somatotopic organization of STN and DBS implications in Parkinson's disease - A case report of a woman "halved" by DBS stimulation.

Brain stimulation·2020
Same author

Stroke-like events after brain radiotherapy: a large series with long-term follow-up.

European journal of neurology·2018
Same author

Incidence of orolingual angioedema after intravenous thrombolysis for stroke.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2018
Same author

Disease activity in progressive multiple sclerosis can be effectively reduced by cladribine.

Multiple sclerosis and related disorders·2018

Related Experiment Video

Updated: Jul 17, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

Clustering of ALS patients in central Italy due to the occurrence of the L84F SOD1 gene mutation.

M Ceroni1, A Malaspina, T E Poloni

  • 1Department of Neuroscience, Istituto Neurologico C Mondino, Pavia, Italy. mceroni@unipv.it

Neurology
|September 25, 1999
PubMed
Summary

A novel SOD1 gene mutation (L84F) was identified in Italian families with Amyotrophic Lateral Sclerosis (ALS), explaining regional ALS clustering. This mutation does not affect SOD1 enzyme activity.

More Related Videos

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
13:31

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis

Published on: February 12, 2015

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice
04:41

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Published on: February 24, 2026

Related Experiment Videos

Last Updated: Jul 17, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
13:31

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis

Published on: February 12, 2015

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice
04:41

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Published on: February 24, 2026

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease.
  • Previous reports of familial ALS in Italy involved a different SOD1 mutation (G41S) without regional clustering.
  • This study investigates ALS cases in a specific rural Italian area with potential familial links.

Purpose of the Study:

  • To investigate the genetic basis of Amyotrophic Lateral Sclerosis (ALS) in three Italian families and sporadic cases from a defined rural region.
  • To identify potential genetic factors contributing to ALS clustering in the area.
  • To analyze the impact of identified mutations on Superoxide Dismutase 1 (SOD1) enzyme activity.

Main Methods:

  • Genetic analysis, including automated and manual sequencing of the SOD1 gene, was performed on familial and sporadic ALS patients.
  • SOD1 enzyme activity and protein levels were assessed in erythrocytes and lymphocytes of affected individuals.
  • Clinical data, including age at onset, disease duration, and progression patterns, were collected and analyzed.

Main Results:

  • A total of 28 affected individuals across six generations in three families were identified.
  • A uniform clinical presentation was observed, characterized by lower limb onset, ascending progression, and lower motor neuron involvement.
  • The L84F missense point mutation in the SOD1 gene was found in all familial ALS patients and one sporadic case, suggesting a common ancestor and explaining regional ALS clustering.
  • SOD1 enzyme activity and protein levels were not significantly altered in patients with the L84F mutation.

Conclusions:

  • The L84F SOD1 mutation is the likely cause of ALS clustering in the studied Italian region, originating from a common ancestor.
  • The L84F mutation is associated with a specific clinical phenotype of ALS.
  • This mutation does not appear to impair SOD1 enzyme activity, suggesting alternative pathogenic mechanisms.